MediSens brings together the clinical and technical community to discuss unmet needs in oncological imaging, with a view to finding solutions from the engineering and medical physics community.
Clinicians will be sharing their view across presentations and panel discussions and with low cost tickets available to medical practitioners, we expect there also to be much active dialogue during networking breaks, amongst our exhibitors and the imaging community.
Clinical highlights on the agenda include:
- Professor Nandita deSouza, Professor of Translational Imaging and Co-Director of the MRI Unit, Institute of Cancer Research sharing her insights on our first day’s clinical panel; assessing the unmet needs in oncological imaging, to discuss the current challenges and performance issues with medical imagers and where R&D teams should focus their efforts for improved results.
- Dr John Dickson, Head of Clinical Nuclear Medicine Physics, University College London Hospital, presenting his perspectives on the clinical advantages and quantitative disadvantages of hybrid imaging
- Consideration of what unmet radiological needs could be addressed by PET/MR, including innovative applications for PET/MR in clinical routine from Professor Dr Ambros J. Beer, Radiologist and Nuclear Medicine Physician
- The NHSE diagnostic perspective on AI and machine learning, wider issues and unmet needs, according to Dr Tony Newman-Sanders, Clinical Director, Diagnostic Imaging, Surrey and Sussex Healthcare, National Clinical Director for Diagnostics, NHS England
- Professor Dr Sanjay Gandhi, Professor of Radiology, Research and Innovation Lead, Core Clinical Services, North Bristol NHS Trust, sharing his experiences with advances in computer-aided cancer detection and machine learning; how should radiologists and oncologists embrace this technology?
- Dr Colin Baker, Head of Radiotherapy Physics, Royal Berkshire NHS Foundation Trust and Professor Christopher Nutting, Professor in Clinical Oncology, Royal Marsden Hospital and The Institute of Cancer Research joining a discussion of challenges in imaging for treatment, in terms of image quality and more